Shares in the UK precision engineering firm jumped after it reported record fourth-quarter revenue and raised its full-year forecasts for both profit and sales, citing strong demand.
The U.S. Office of the Comptroller of the Currency rejected the fintech's bid for a national trust bank charter, delaying its plan to directly access the U.S. payments system and lower operational costs.
With a quarter of companies reporting, U.S. earnings are up 23% and European earnings are up 22% year-over-year, significantly outpacing analyst expectations, according to a JPMorgan research note.
Indonesia's main stock index closed sharply lower on Friday, dragged down by widespread losses in the infrastructure, financial, and agriculture sectors amid a weakening rupiah.
The Zurich-based wealth manager's stock rose after it reported a sharp increase in first-half net profit, growth in assets under management, and key strategic updates.
The French pharmaceutical company will not pursue regulatory filings for the experimental drug, citing weaker efficacy and safety concerns from late-stage testing. The move signals a potential overhaul of Sanofi's R&D pipeline.
The Finnish technology group's stock surged nearly 20% after reporting better-than-expected Q2 results and launching a review to potentially separate into two publicly listed companies.
Novo Nordisk is asking a U.S. court for a preliminary injunction to halt advertisements from rival Eli Lilly, escalating a legal battle over allegedly misleading claims in the lucrative obesity drug market.
Volkswagen shares declined after the German automaker reported a significant second-quarter earnings miss and reversed its full-year revenue forecast from growth to a potential decline.
